Gloria Lutzny-Geier

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Venues

Leukemia & lymphoma

Stem cells (Dayton, Ohio)

Cell death & disease

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Franziska Gsottberger, Christina Meier, Anna Ammon, Scott Parker, Kerstin Wendland, Rebekka George, Srdjan Petkovic, Lisa Mellenthin, Charlotte Emmerich, Gloria Lutzny-Geier, Markus Metzler, Andreas Mackensen, Vidyalakshmi Chandramohan, Fabian Müller
Targeted inhibition of protein synthesis renders cancer cells vulnerable to apoptosis by unfolded protein response. Cell death & disease 14 (8) (2023)
Franziska von Heydebrand, Maximilian Fuchs, Meik Kunz, Simon Voelkl, Anita N Kremer, Robert A J Oostendorp, Jochen Wilke, Michael Leitges, Alexander Egle, Andreas Mackensen, Gloria Lutzny-Geier
Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia. Stem cells (Dayton, Ohio) 39 (6) (2021)
Sarah Handl, Franziska von Heydebrand, Simon Voelkl, Robert A J Oostendorp, Jochen Wilke, Anita N Kremer, Andreas Mackensen, Gloria Lutzny-Geier
Immune modulatory effects of Idelalisib in stromal cells of chronic lymphocytic leukemia. Leukemia & lymphoma 62 (11) (2021)
Maurizio Mangolini, Frederik Götte, Andrew Moore, Tim Ammon, Madlen Oelsner, Gloria Lutzny-Geier, Ludger Klein-Hitpass, James C Williamson, Paul J Lehner, Jan Dürig, Michael Möllmann, Lívia Rásó-Barnett, Katherine Hughes, Antonella Santoro, Simon Mendez-Ferrer, Robert A J Oostendorp, Ursula Zimber-Strobl, Christian Peschel, Daniel J Hodson, Marc Schmidt-Supprian, Ingo Ringshausen
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia. Nature communications 9 (1) (2018)

Gloria Lutzny-Geier.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gloria Lutzny-Geier